Phase IV
Atopic Dermatitis: A Study of Upadacitinib in Adult Subjects with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (SWITCH-UP)
- Study HIC#:2000037430
- Last Updated:03/24/2026
Contact Us
For more information about this study, including how to volunteer, contact:
Marianne Sparapani-Rusgrove
- Phone Number: 1-203-737-6879
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
